An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. by Agostinis, C. et al.
of November 14, 2016.
This information is current as
Development
Trophoblast Invasion and Placental
and Tissue Remodeling: Contribution to 
An Alternative Role of C1q in Cell Migration
and Francesco Tedesco
Angela Santoni, Berhane Ghebrehiwet, Guillermina Girardi 
Cecilia Garlanda, Francesco De Seta, Paola Spessotto,
Gismondi, Helena Stabile, Fleur Bossi, Carla Guarnotta, 
Chiara Agostinis, Roberta Bulla, Claudio Tripodo, Angela
http://www.jimmunol.org/content/185/7/4420
doi: 10.4049/jimmunol.0903215
September 2010;
2010; 185:4420-4429; Prepublished online 1J Immunol 
Material
Supplementary
5.DC1.html
http://www.jimmunol.org/content/suppl/2010/09/01/jimmunol.090321
References
http://www.jimmunol.org/content/185/7/4420.full#ref-list-1
, 23 of which you can access for free at: cites 65 articlesThis article 
Subscriptions
http://jimmunol.org/subscriptions
 is online at: The Journal of ImmunologyInformation about subscribing to 
Permissions
http://www.aai.org/ji/copyright.html
Submit copyright permission requests at: 
Email Alerts
http://jimmunol.org/cgi/alerts/etoc
Receive free email-alerts when new articles cite this article. Sign up at: 
Print ISSN: 0022-1767 Online ISSN: 1550-6606. 
Immunologists, Inc. All rights reserved.
Copyright © 2010 by The American Association of
9650 Rockville Pike, Bethesda, MD 20814-3994.
The American Association of Immunologists, Inc.,
 is published twice each month byThe Journal of Immunology
 by guest on N
ovem
ber 14, 2016
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
 by guest on N
ovem
ber 14, 2016
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
The Journal of Immunology
An Alternative Role of C1q in Cell Migration and Tissue
Remodeling: Contribution to Trophoblast Invasion and
Placental Development
Chiara Agostinis,*,†,1 Roberta Bulla,*,1 Claudio Tripodo,‡ Angela Gismondi,x
Helena Stabile,x Fleur Bossi,*,† Carla Guarnotta,‡ Cecilia Garlanda,{ Francesco De Seta,†,‖
Paola Spessotto,# Angela Santoni,x Berhane Ghebrehiwet,** Guillermina Girardi,†† and
Francesco Tedesco*
Fetal trophoblast cells invading the decidua in the early phase of pregnancy establish complex interaction with the maternal ex-
tracellular matrix. We discovered that C1q was widely distributed in human decidual stroma in the absence of C4 and C3 and was
actively synthesized by migrating extravillous trophoblasts. The cells expressed the messages for the three chains of C1q and se-
creted this complement component that interacted with the proteins of the decidual extracellular matrix. Solid phase-bound C1q
promoted trophoblast adhesion and migration, and cell binding to C1q resulted in activation of ERK1/2 MAPKs. Ab inhibition
experiments showed that the receptors for the globular head of C1q/p33 and a4b1 integrin were both involved in this process and
were colocalized on the cell surface following binding of C1q to trophoblasts. We also found that C1q2/2 mice manifested
increased frequency of fetal resorption, reduced fetal weight, and smaller litter sizes compared with wild-type mice. C1q deficiency
was associated with impaired labyrinth development and decidual vessel remodeling. Collectively, these data suggest that C1q
plays an important role in promoting trophoblast invasion of decidua and that defective local production of C1q may be involved
in pregnancy disorders, such as pre-eclampsia, characterized by poor trophoblast invasion. The Journal of Immunology, 2010,
185: 4420–4429.
T
he placenta is a new organ formed in pregnancy with the
contribution of both the fetus and the mother and is abso-
lutely essential to promote a peaceful feto–maternal in-
teraction with continuous exchange of nutrients and protective fac-
tors. A characteristic feature of this interaction during placentation
is the invasion of maternal decidua by fetal cytotrophoblasts (CTBs)
that depart from the anchoring villi and migrate as extravillous
trophoblasts (EVTs) into the maternal decidua, reaching the inner
third of the myometrium (1). Some of the invading trophoblast cells
penetrate the spiral arteries and migrate upward against blood
flow, forming intravascular islands and mosaic vessels as a result
of partial replacement of the endothelium (2, 3). Trophoblast cells
share with tumor cells the ability to invade tissues, with the major
difference that trophoblast invasion is a physiological event strictly
restricted to pregnancy and spatially limited to the decidual mi-
croenvironment (4–7). Impairment of this process results in patho-
logical conditions associated with pregnancy including intrauterine
growth restriction and pre-eclampsia (8, 9).
CTBs migrating from chorionic villi into the decidua undergo
a process of differentiation into the EVT cell lineage characterized
by a progressive change in the surface expression of adhesion
molecules that allow these cells to leave the chorionic villi and bind to
the extracellular matrix (ECM) of decidua (10–13). The epithelial-
like receptors E-cadherin and a6b4 integrin expressed on villous
trophoblasts are replaced by the adhesion molecules vascular en-
dothelial cadherin, VCAM-1, and PECAM-1, characteristic of en-
dothelial cells (ECs). In addition, EVTs express a variety of integrins
that promote their binding to ECM of decidua (14). ECM proteins
establish a special interaction with EVTs and, by virtue of their
characteristic distribution, favor the invasion of decidua and the
characteristic perivascular localization (15). Fibronectin (FN) is one
of the most abundant ECM proteins distributed preferentially in the
distal portion of the CTB column and in areas of decidua invaded
by trophoblasts (16). This protein acts as a bridging ligand for
a5b1 integrin expressed on EVTs and mediates their adhesion and
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migration at sites of anchoring villi and in the decidual tissue (17).
Decidual stroma is also rich in laminins that surround the decidual
cells as a distinct pericellular layer (18, 19) and interact mainly with
a1b1 and a6b1 on EVTs (20, 21).
Elastin microfibril interfacer 1 (EMILIN1) is a connective tissue
glycoprotein associated with elastic fibers (22) previously identi-
fied as another candidate ECMmolecule involved in EVT invasion.
A characteristic feature of this protein is to display a gradient dis-
tribution in decidua with a progressive increase in its expression
toward remodeled spiral arteries that favors EVT migration from
the anchoring columns to the perivascular areas (23). EMILIN1
shares a structural homology with the globular head of C1q (gC1q),
the first component of the complement system (24), raising the
possibility that C1q may contribute to trophoblast invasion of de-
cidua. The main function of this complement component is to act
as a recognition molecule of the complement system and trigger
the activation of the classical pathway. This results in the release
of biologically active products primarily involved in the removal
of immune complexes and infectious and other harmful agents
through the activation of various cellular responses, including en-
hancement of phagocytosis (25), stimulation of neutrophil, eosin-
ophil, and mast cell chemotaxis (26), and clearance of apoptotic
cells (27). However, C1q has also been shown to exhibit activities
apparently unrelated to its defensive functions, such as promotion
of EC adhesion and spreading (28) and regulation of fibroblast
migration and apoptosis (26). Over the last few years, we have been
analyzing human placenta for the presence and distribution of
complement components with the aim to define their role in embryo
implantation. Recently, we have shown that C1q is expressed on the
surface of decidual ECs (DECs) and acts as a molecular bridge that
favors adhesion of endovascular trophoblasts and endothelial re-
placement (29). Data are now presented suggesting that invasive
trophoblast cells synthesize and secrete C1q that binds to ECM
proteins and is used by EVTs to invade the decidua.
Materials and Methods
Abs and reagents
Goat antiserum anti-human C1q, mAb anti-human C1q, and purified human
C1q were purchased from Quidel (San Diego, CA). Two mAbs anti-gC1q
receptor (gC1qR; clones 74.5.2 and 60.11) recognizing distinct domains of
the molecule were previously reported (30); rabbit IgG anti-human cC1qR/
calreticulin and anti-gC1qR/p33 were previously reported (31). The neu-
tralizing mAb M89D3 to CD31 was kindly provided by M. R. Zocchi (San
Raffaele Hospital, Milan, Italy) (32, 33); rabbit IgG and mAb P1H4 to
human b1 integrin, mAb P5D2 to a4 integrin, mAb CGA7 to human
smooth muscle a-actin, and mAb 349 anti-paxillin were from Chemicon
(Milan, Italy). Rabbit IgG to human C1q and to cow cytokeratin wide
spectrum, mAb W6/32 anti-HLA, mAb OV-TL 12/30 anti-cytokeratin 7,
mAb F8/86 mouse anti-human von Willebrand factor (vWF), mAb SS2/36
anti-human CD10, mAb SN6h anti-human CD105, and mAb WM-47
mouse anti-human CD13 were purchased from DakoCytomation (Milan,
Italy). Rabbit antiserum to ERK MAPK was from Santa Cruz Bio-
technology (Santa Cruz, CA), and mAb anti–p-ERK1/2 MAPK from
Cell Signaling Technology (Danvers, MA); mAb MEM-G9 anti-human
HLA-G was from Immunological Science (Friesoythe, Germany); and
Cy3-conjugated F(ab9)2 goat anti-mouse IgG was from Jackson Immu-
noResearch Laboratories (West Grove, PA). The IgG were purified from
the antisera by affinity chromatography on protein G-Sepharose columns
(GE Healthcare, Milan, Italy) and, when required, biotin-labeled as pre-
viously reported (34).
Alkaline phosphatase-conjugated goat anti-mouse IgG, alkaline phos-
phatase-conjugated goat anti-rabbit IgG, mouse IgG1 isotype-matched
Abs, mAb V9 anti-human vimentin, and mAb UCHM-1 anti-human CD14
were from Sigma-Aldrich (Milan, Italy), and mAb 5D3 to human cyto-
keratin 8/18 was from Novocastra (Milan, Italy). Monoclonal 2D1 anti-
human CD45 was from BD Biosciences (Milan, Italy).
The gC1q fragment was kindly provided by G. J. Arlaud (Institut de
BiologieStructurale,Grenoble, France). FNwaspurchased fromCalbiochem-
Novabiochem (La Jolla, CA). Vitronectin was purified from human plasma as
previously described (35). Human collagen type (COLL) II, III, IV, and V,
human plasma fibrinogen, and high m.w. hyaluronan were obtained from
Sigma-Aldrich; rat tail COLL I was purchased from BD Biosciences. Native
laminin-1–nidogen complex from Engelbreth-Holm-Swarm mouse tumor
was obtained as previously described (36). Chick COLLVI tetramers were
purified as previously described (37). Tenascin and human perlecan were
kindly provided by Luciano Zardi (Advanced Biotechnology Centre, Genoa,
Italy) and Anders Malmstro¨m (Lund University Hospital, Lund, Sweden),
respectively. The synthetic peptide DELPQLVTLPHNLHGPEILDVPST
(CS-1), the cell-attachment site of FN, was synthesized and purified as pre-
viously described (38).
Human tissues
Placenta and decidual biopsy specimens were obtained from women un-
dergoing elective termination of pregnancy at 8–12 wk gestation. This
study was approved by the institutional board of the Maternal-Children’s
Hospital (Istituto Di Ricovero e Cura a Carattere Scientifico “Burlo Garo-
folo,” Trieste, Italy), and informed consent was obtained from women
providing the tissue specimens.
Immunohistochemical staining
Tissue samples were fixed in 10% buffered formalin and paraffin embedded.
Four-micrometer–thick sections of placental tissue were stained with H&E
and examined for the presence and distribution of invasive trophoblasts. For
immunohistochemical analysis, the slides were microwaved three times in
Tris-HCl/EDTA (pH 9) buffer (DakoCytomation) for 5 min, brought to
room temperature, and washed in PBS. Postneutralization of the endoge-
nous peroxidase with H2O2 for 10 min, the sections were first incubated
with protein block (Novocastra) for 10 min. Sections were incubated with
the appropriate primary Abs for 30 min at room temperature. Binding of
anti-C1q IgG or anti-cow cytokeratin wide spectrum were detected using the
Labeled StreptAvidin Biotin + HRP kit and diaminobenzidine as substrate
(DakoCytomation) and that of mAb anti-cytokeratin 7 was revealed with the
Alkaline Phosphatase Anti-Alkaline Phosphatase Complex (DakoCytoma-
tion) and 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt/NBTor Fast
Red (DakoCytomation) as chromogens. The sections were viewed under
a Leica DM3000 optical microscope (Leica Microsystems, Mannheim,
Germany), and captions were collected using a Leica DFC320 digital camera
(Leica Microsystems).
Cell isolation and culture
CTBs were purified from placental specimens postremoval of decidual
tissue and fetal membrane as previously described (2). Briefly, placental
tissue was incubated with HBSS containing 0.25% trypsin and 0.2 mg/ml
DNase (Roche, Milano, Italy) for 20 min at 37˚C. Postfractionation
through Percoll gradient, the leukocytes were totally removed by immu-
nomagnetic beads coated with mAb to CD45 (Dynal, Invitrogen, Milan,
Italy). CTBs collected by negative selection were seeded in a 25-cm2 flask
coated with 5 mg/cm2 FN (Roche), cultured overnight in RPMI (Life
Technologies, Invitrogen) supplemented with 10% FCS, and finally de-
tached by trypsin-EDTA treatment. The cells obtained under these con-
ditions contained 95% cytokeratin 7-positive CTBs and a few vimentin-
positive decidual stromal cells (DSCs). The presence of contaminating
leukocytes and ECs was excluded by RT-PCR assay for CD45 and FACS
analysis with anti-vWF and anti-CD31 Abs, respectively.
HLA-G+ and HLA2 cells were purified by incubating freshly isolated
CTBs (33 106) with Dynabeads M-450 (Dynal, Invitrogen) conjugated with
mAb anti-human HLA-G at 4˚C for 45 min with gentle rotation. The cells
adsorbed tomagnetic beads were collected with a magnetic collector, washed
five times with Dulbecco’s PBS containing 0.1% BSA (Sigma-Aldrich), and
used as a source of HLA-G–positive CTBs. The unadsorbed cells were in-
cubated with CD45 magnetic beads (Invitrogen) to remove contaminating
leukocytes and subsequently with Dynabeads M-450 conjugated with mAb
W6/32 that recognized a conserved epitope of human HLA-A, -B, and -C
at 4˚C for 45 min with gentle rotation. The negatively selected cells were
100% HLA negative.
DSCs were isolated as described by Carlino et al. (39). Briefly, decidual
tissue was digested with 0.5% trypsin (Sigma-Aldrich), 50 mg/ml DNase1
(Boehringer Mannheim, Mannheim, Germany) in HBSS overnight at 4˚C
and then treated with collagenase type I (3 mg/ml; Worthington Bio-
chemical, Milan, Italy) for 30 min at 37˚C. After Ficoll (Roche) density
gradient centrifugation, the decidual cells were cultured for 24 h in RPMI
supplemented with 10% FCS, and the decidual cell-conditioned medium
(DCCM) was collected, stored at280˚C, and used as source of chemotactic
stimuli in the migration assays. Nonadherent cells were removed by ex-
tensivewashing, and adherent cells were used at the third passage of culture.
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Under these conditions, the cells were negative for CD14, CD45, cytoker-
atin 8-18, vWF, or CD31 and positive for a-actin, vimentin, CD13, CD10,
and CD105.
Peripheral blood-derived macrophages (PBDMs) were obtained from
Ficoll-purified PBMCs cultured for 7 d in RPMI supplemented with 10%
FCS as previously described (40).
RT- and real-time quantitative PCR
Cells and tissues were harvested in Omnizol (Euroclone, Milan, Italy)
according to the supplier’s instructions. Total RNA was extracted and re-
verse transcripted as previously described (29). RT-PCR was performed in
a Techne TC-312 thermal cycler (Boneworld Scientific, Milan, Italy) using
Taq DNA polymerase (AccuTaq, Sigma-Aldrich).
Real-time quantitative PCR (RQ-PCR) was carried out on a Rotor-Gene
6000 (Corbett, Explera, Ancona, Italy) using iQ SYBR Green Supermix
(Bio-Rad, Milan, Italy). Table I lists the primers used for PCR following
Kaul and Loos (41). Amplification conditions, sequences, and concen-
trations of the primers are similar to those of RT-PCR. The melting curve
was recorded between 55˚C and 99˚C with a hold every 2 s. Purified C1qC
and b-actin PCR products synthesized from pooled deciduas were used to
establish standard curves, and the data were analyzed using Rotor-Gene
Software (Corbett, Explera). The relative amount of C1qC in each sample
was normalized with b-actin and expressed as arbitrary units (AUs) con-
sidering 1 AU obtained in PBDMs used as positive control (42).
Immunoenzymatic assays
The level of C1q secreted by CTBs in the culture supernatant and the
presence of gC1qR in immunoprecipitated samples were measured by
a sandwich ELISA as previously described (43).
ECM proteins (25 mg/ml) bound to wells of 96-well ELISA plates
(Corning Costar, Acton, MA) in 0.1 mM sodium bicarbonate buffer (pH
9.6) by overnight incubation at 4˚C were tested for their interaction with
C1q. Hyaluronan and laminin-5 were used at the concentration of 50 mg/
ml and 11.5 mg/ml, respectively. After washing the wells with PBS con-
taining CaCl2 and MgCl2 (0.7 mM) and 0.05% Tween-20 and blocking the
residual-free sites with PBS plus 1% BSA for 1 h at 37˚C, C1q was added
at the concentration of 10 mg/ml in PBS plus 1% BSA containing 0.05%
Tween-20 and 0.7 mM Ca2+ and Mg2+ and allowed to bind to ECMs for 90
min at 37˚C. Bound C1q was revealed using mAb anti-C1q (1 mg/ml)
followed by alkaline phosphatase-conjugated goat anti-mouse IgG.
CTB adhesion and migration assays
Adhesion and migration of CTBs were measured as previously reported
(19). Briefly, CTBs (105 cells/100 ml) were labeled with the fluorescent
dye FAST Dil (Molecular Probes, Invitrogen) and added to C1q-coated
wells of a 96-well plate (Iwaki, Bibby Scientific Italia, Milan, Italy) for
30 min at 37˚C in an air/CO2 incubator. The number of adherent cells were
counted with Infinite200 (absorbance 544 nm, emission 590 nm) (TECAN
Italia, Milan, Italy) and referred to a calibration curve established with an
increasing number of labeled cells.
The migration assay was performed in transwell chambers using FAST
Dil-labeled (Molecular Probes, Invitrogen) CTBs (2 3 105 cells) resus-
pended in RPMI with 0.1% BSA and added to the upper chamber. The cells
were allowed to migrate through HTS FluoroBlokTM polycarbonate inserts
with 8-mm pores (Becton Dickinson, Falcon, Milan, Italy) coated on the
upper side with C1q, FN, or BSA, all used at the concentration of 40 mg/ml.
For some experiments, the membranes were first coated with FN (20mg/ml)
and then incubated with C1q (20 mg/ml) for 30 min at room temperature to
allow interaction of C1q with bound FN. DCCMs obtained by culturing
decidual cells for 24 h and diluted 1:2 in RPMI with 0.1% BSAwere added
to the lower chamber as a chemoattractant for CTBs. The number of cells
transmigrated to the lower side of the insert after 4 h was evaluated as in-
dicated above for the adherent cells.
Immunoprecipitation and immunoblot analysis
CTBs (23 106) were allowed to adhere towells coated with BSA (10mg/ml),
FN (10mg/ml), or C1q (10mg/ml) for 30min at 37˚C in RPMIwithout serum.
At the end of incubation, both adherent and nonadherent cells were recovered
and lysed in ice-cold lysis buffer containing 1% (v/v) Nonidet P-40 (Sigma-
Aldrich), 1 mM CaCl2, 1 mM MgCl2, 0.1% NaN3, 1 mM PMSF, 2 mg/ml
aprotinin, 2mg/ml leupeptin, and 150mMNaCl in 50mMTris (pH 7.5) for 30
min at 4˚C. Cell lysates were centrifuged at 15,000 3 g for 10 min at 4˚C,
preclearedwith 100ml 20% suspension of protein G-Sepharose beads (Sigma-
Aldrich) for 1 h at 4˚C, and sequentially immunoprecipitated with normal
mouse IgG (Sigma-Aldrich), mAb 60.11 anti-C1qR, and mAb 4B4 anti-b1
integrin (Beckman Coulter, Fullerton, CA) previously bound to protein
G-Sepharose beads. After washing with Tris buffer (50 mM, pH 7.4) con-
taining 150 mM NaCl, 5 mM EDTA-Na, 0.25% Triton X-100 (Sigma-
Aldrich), and 0.1% SDS, the immune complexes were resuspended in sam-
ple buffer with 2-ME, boiled for 3 min, resolved on 9% SDS-PAGE, and
transferred to nitrocellulose membrane (Schleicher & Schuell, Dussel, Ger-
many). The membrane was then sequentially immunoblotted with rabbit IgG
against the b1 integrin subunit and mAb against gC1qR (mAb 60.11). Im-
munoreactivity was revealed using an ECL kit (Amersham International,
Amersham, U.K.).
Phosphorylation of ERK1/2 MAPKs in trophoblast cells
CTB cells were left to adhere to C1q (20 mg/ml), FN (20 mg/ml), or BSA-
coated (20 mg/ml) wells for the indicated periods of time at 37˚C. At the
end of the incubation time, ice-cold lysis buffer was added, and an equal
amount of total cell lysates were resolved by 9% SDS-PAGE, transferred to
nitrocellulose, and sequentially immunoblotted with anti-phosphorylated
ERK1/2 mAb and anti-ERK antiserum. Immunoreactivity was revealed as
described above. The amount of p-ERK1/2 MAPK was quantified by
densitometric analysis using the ImageJ 1.37v program (National Institutes
of Health, Bethesda, MD).
Confocal analysis
CTBs were plated at 37˚C on eight-chamber culture slides (BD Biosciences
Discovery Labware, Milan, Italy) coated with C1q (10 mg/ml) or FN (10 mg/
ml) and left to adhere for various lengths of time between 15 min and 2 h.
Postfixation, the cells were permeabilized and stained withN-(7-nitrobenz-2-
oxa-1,3-diazol-4-y)-conjugated phallacidin (NBD-phallacidin) (Molecular
Probes, Invitrogen) and mAb antipaxillin followed by Cy3-conjugated
F(ab9)2 goat anti-mouse IgG (1:300) as previously described (19).
In other experiments, the C1q-bound CTBs were fixed with 3% para-
formadehyde and incubated with Ultra V Block (Lab Vision, Bio Optica
Milan, Milan, Italy) for 10 min at room temperature. The cells were then
incubated with mAb P1H4 anti-human b1 integrin (2 mg/ml) for 1 h at room
temperature followed by Cy3-conjugated F(ab9)2 goat anti-mouse IgG.
After extensive washing and blocking with mouse serum (1:100) in Ultra V
Block (Lab Vision) for 10 min, the cells were incubated with biotin-labeled
mAb anti-gC1qR 74.5.2 for a further 1 h at room temperature followed by
FITC-conjugated streptavidin (1:100) (DakoCytomation).
Images were acquired with a Leica TCS SP2 confocal system (Leica
Microsystems) using the Leica Confocal Software and a 633 fluorescence
objective on a Leica DM IRE2 microscope (Leica Microsystems) or with
a Nikon C1Si confocal system, using the Nikon EZ-C1 Confocal Software
and a 633 fluorescence objective on a Nikon TE2000-U inverted micro-
scope (Nikon, Melville, NY).
Table I. Primers used for PCR analysis in accord to the method of Kaul and Loos (41)
Sample Primers Sequence 59→ 39
Annealing
Temperature (˚C)
Size of PCR
Product (bp)
EMBL Database
Accession No.
b-actin Forward CTACAATGAGCTGCGTGTGG 59 528 M10278
Reverse AAGGAAGGCTGGAAGAGTGC
C1qA Forward ATGGTGACCGAGGACTTGTG 62 276 BC071986
Reverse GTCCTTGATGTTTCCTGGGC
C1qB Forward ACCCCAGGGATAAAAGGAGAG 60 216 BC008983
Reverse GGCAGAGAAGGCGATTTTCTG
C1qC Forward AAGGATGGGTACGACGGACTG 65 213 NM_172369
Reverse TTTCTGCTTGTATCTGCCCTC
EMBL, European Molecular Biology Laboratory.
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Pregnancy studies in mice
Eight- to 10-wk-old virgin female C57BL/6 (The Jackson Laboratory, Bar
Harbor, ME) and C1q-deficient mice (provided by Dr. Marina Botto, Im-
perial College, London, U.K.) were mated with 8–14-wk-old C57BL/6 or
C1q-deficient mice, respectively. A group of pregnant females was killed at
day 15, and the frequency of fetal resorption was calculated as previously
described (44). Fetal weights were also determined. Some mice were
studied until delivery, and the litter sizes were recorded at birth. Procedures
that involved mice were approved by the Institutional Animal Care and Use
Committee of the Hospital for Special Surgery and were conducted in strict
accordance with guidelines for the care and use of laboratory research
animals promulgated by the National Institutes of Health.
Immunohistochemical studies were performed on implantation sites
from 6–8-wk-old pregnant mice kept at the Animal House of Istituto
Clinico Humanitas (Rozzano, Italy) and collected at days 9.5, 10.5, and
12.5 of pregnancy. The experimental procedures were performed in ac-
cordance with the institutional guidelines and in compliance with the
European (86/609/EEC) and Italian (D.L.116/92) laws.
Statistical analysis
The results are expressed as the mean 6 SD. Statistical significance was
determined using the Student t test to compare two groups of data. Values
of p # 0.05 were considered to be statistically significant.
Results
C1q is localized in areas of invading trophoblasts
Immunohistochemical analysis of paraffin-embedded first-trimester
placentawith rabbit IgG to humanC1q showed awide distribution of
this complement component in the decidual stroma in thevesselwall.
A strong signal was also seen in the Hofbauer cells (Fig. 1B, arrow)
and in limited surface areas of the villi, whereas the overall staining
of syncytiotrophoblasts and the underlying CTB layer of the villi
was fainter (Fig. 1B). This finding was confirmed using goat IgG
anti-C1q. Double staining of tissue sections for C1q and cytokeratin
7 to identify trophoblast cells documented the presence of C1q on
trophoblasts localized in the trophoblast shell (Fig. 1C) and at the
level of the CTB columns on their way to invade the decidua (Fig.
1D). Staining for C1q was particularly evident in the EVT spread in
the decidua (Fig. 1E) and surrounding the spiral arteries (Fig. 1F),
and a closer analysis of these cells revealedmarked cytoplasmic C1q
localization. We failed to detect C4 and C3 in the decidual tissue at
sites of C1q deposition (Supplemental Fig. 1).
CTB cells express C1q at mRNA and protein level
The finding of intracellular staining for C1q in EVTs led us to
investigate these cells for their ability to synthesize and secrete this
complement component. Initially, we performed RT-PCR for the
three chains of C1q (A, B, and C) on mRNA extracted from the
whole placenta, CTBs, DSCs, the most abundant cells present in
decidua, and PBDMs examined as a positive control. The results
presented in Fig. 2 show that mRNA for the three chains was
expressed in PBDMs and in whole decidual tissue, suggesting
local production of C1q. Analysis of decidual cells revealed the
presence of the three transcripts in CTBs, whereas DSCs express
only the mRNA for the A chain (Fig. 2A).
Because C1q was observed predominantly in invasive tropho-
blasts, we hypothesized that the expression of C1q in CTBs was
correlated with the acquisition of the invasive phenotype by these
cells. To confirm this possibility, we analyzed CTBs expressing
HLA-G, a marker of invasive trophoblasts, and HLA-negative
cells, including villous trophoblasts, by RQ-PCR for the presence of
mRNA for C1qC that discriminates C1q-secreting from nonsecret-
ing cells (29). As shown in Fig. 2B, HLA-G+ cells expressed amounts
of mRNA C1qC essentially similar to those detected in PBDMs,
whereas HLA2 CTBs failed to express the C1qC transcript.
Next, we investigated the ability of CTBs to synthesize and
secrete C1q. For this purpose, 106 invading CTBs were plated in
multiwell chambers, and the cell supernatants were collected after
48 h of culture and stored at280˚C. The amount of C1q measured
by ELISA in these samples varied between 50 and 100 ng/106
cells and was approximately half of the amount of C1q secreted by
PBDMs (Fig. 2C).
C1q secreted by trophoblasts is used by these cells to invade
the decidua
Having found that C1q is secreted by the invading CTBs and widely
distributed in decidua,we sought to investigate the role played by this
complement component in trophoblast motility. To evaluate cell
binding to C1q, freshly isolated CTBs were labeled with the fluo-
rescent probe FAST Dil and allowed to adhere to solid phase-bound
C1q or purified gC1q in 96-well plates for 30min at 37˚C, usingBSA
and FN as negative and positive controls, respectively. Approxi-
mately 40% of CTBs adhered to C1q as opposed to 20% of cells
adhering to BSA and 60% to FN. Interestingly, the percentage of
CTBs binding to gC1q was essentially similar to that observed with
the whole C1q molecule, suggesting that trophoblast cells interact
with the globular domain of the molecule (Fig. 3A).
CTBs attached to C1q exhibited a morphologic appearance
different from that of FN-bound cells, being much smaller and
displaying wide ruffles that extended in multiple directions, in
contrast with the marked spreading of CTBs adherent to FN (Fig.
3B). Staining of FN-bound cells with NBD-phallacidin revealed
a high number of actin-containing stress fibers and localization
of paxillin at the tips of stress fibers already 30 min after cell
adhesion. In contrast, the cells attached to C1q showed diffuse
FIGURE 1. Localization of C1q in first-trimester human placenta.
Single staining of section of maternal decidua and villi with rabbit IgG
anti human-C1q (B) or unrelated rabbit IgG (A) developed with the La-
beled StreptAvidin Biotin + HRP kit (DakoCytomation) and dia-
minobenzidine as substrate. The sections were counterstained with
hematoxylin (DakoCytomation). Double staining of maternal decidua and
villi sections with rabbit IgG anti–human-C1q (brown) and mAb OU-TL
12/30 to human cytokeratin 7 (1:50) developed with Alkaline Phosphatase
Anti-Alkaline Phosphatase Complex (DakoCytomation) and NBT/5-
bromo-4-chloro-3-indolyl phosphate p-toluidine salt (DakoCytomation)
as chromogen (blue) (C, D) or Fast Red (magenta) (E, F). Original mag-
nification 3400. Note the failure of villous CTBs and syncytiotropho-
blasts to stain for C1q (B) in contrast with the positive staining of two
positive Hofbauer cells (B, arrow) and the wide distribution of C1q
staining in the decidual stroma (C, D). Note also staining for C1q in EVTs
migrating into decidua (C–E, see arrows) or localized around spiral
arteries (F, see arrows). SA, spiral artery.
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positivity for paxillin and subcortical organization of actin at the
same time point (Fig. 3B), but some focal plaques were seen after
2 h of CTB adhesion (data not shown).
Next, we examined C1q and FN for their ability to promote CTB
migration. The upper side of the transwell inserts was coated with
C1q or FN or both, and CTBs were allowed to migrate in the
presence or in the absence of DCCMs added to the lower chamber
as a chemotactic stimulus. C1q and FN caused migration of ∼10%
of CTBs in the absence of DCCMs (data not shown). This value
raised to 24% when the cells were allowed to migrate through FN
in the presence of DCCMs and further increased to 41% through
the insert coated with C1q (Fig. 3C), suggesting that this com-
plement component was more efficient than FN in promoting CTB
migration.
To mimic more closely the situation encountered by CTBs that
interact with the ECM while invading the decidua, the insert of the
transwell was first coated with FN and then with C1q. FN was
selected as one of the ECMmolecules largely expressed in decidua
and found to strongly interact with C1q (Supplemental Fig. 2). The
results presented in Fig. 3C clearly show that C1q bound to FN
maintains the ability to support migration of 40% CTBs.
gC1qR and b1 integrin are involved in trophoblast–C1q
interaction
We have previously shown that gC1qR/p33 (gC1qR) on endo-
vascular trophoblasts is involved in the adhesion of these cells to
DECs expressing C1q on their surface (29). To evaluate the
contribution of gC1qR to CTB–C1q interaction, the adhesion as-
say was performed using CTBs preincubated with two different
Abs to gC1qR, mAb 60.11 or mAb 74.5.2, that recognize distinct
epitopes on the molecule, or an Ab to cC1qR for 30 min at 37˚C.
As shown in Fig. 4A, the adhesion of CTBs to C1q was inhibited
almost completely by mAb 60.11, whereas the other mAb 74.5.2
to gC1qR and the rabbit IgG to cC1qR were ineffective. Based on
our previous findings that trophoblast cells use a4b1 integrin to
interact with EMILIN1, a member of C1q family proteins sharing
a gC1q signature domain (19, 45), we examined the effect of
neutralizing Abs to a4 and b1 integrin in the adhesion assay. Our
results (Fig. 4A) suggest that both a4 and b1 integrin are also
involved in CTB adhesion to C1q, and the same molecules appear
to play a role in trophoblast migration through C1q (Fig. 4B).
FIGURE 3. C1q mediates CTB adhesion and migration. A, Adhesion of
FAST Dil-labeled (Molecular Probes, Invitrogen) CTBs to wells of 96-well
plates coated with C1q, gC1q, FN, or BSA at the concentration of 10 mg/
ml was measured after 30 min of incubation at 37˚C. The results are given
as percent of cell adhesion with reference to a calibration curve established
with an increasing number of labeled cells. Data from five independent
experiments are presented as mean 6 SD. pp , 1 3 1025. B, CTBs plated
for 30 min on eight-chamber culture slides coated with FN (upper panel)
or C1q (bottom panel), fixed, and stained with NBD-phallacidin (green)
and mouse monoclonal anti-paxillin Ab followed by Cy3-conjugated goat
anti-mouse IgG (red) were analyzed by confocal microscope. Original
magnification 3600. Note the presence of actin-containing stress fibers
and focal adhesion formation in cells attached to FN and, conversely,
subcortical actin organization and diffuse positivity for paxillin in cells
bound to C1q. Confocal microscope images were acquired with a Nikon
C1Si confocal system using the Nikon EZ-C1 Confocal Software and
a 633 fluorescence objective on a Nikon TE2000-U inverted microscope
(Nikon). C, Migration of CTBs was evaluated using FAST Dil-labeled cells
(2 3 105) added to the upper chamber of a transwell and allowed to mi-
grate for 4 h through inserts coated with FN (40 mg/ml), C1q (40 mg/ml),
or C1q (20 mg/ml)–FN (20 mg/ml) complex in the presence of DCCMs
added to the lower chamber as a chemotactic stimulus. The results ob-
tained from four independent experiments are shown as percent of cell
migration and presented as mean 6 SD. pp , 0.05.
FIGURE 2. CTBs express C1q at mRNA and protein level. RNA pre-
pared from PBDMs, first-trimester decidua, and freshly isolated CTBs and
DSCs were analyzed for C1qA, -B, and -C and b-actin expression by RT-
PCR (A). The relative amount of mRNA for C1qC in PBDMs, total CTBs,
HLA-G+, and HLA2 CTBs was evaluated by RQ-PCR and normalized
with reference to the b-actin value. The results were expressed as AUs, in
which 1 AU represents the value obtained with PBDMs used as a positive
control (B). Levels of C1q secreted by CTB and, for comparison, by
PBDMs and DSCs was measured in the cell supernatant by ELISA after 48
h of culture using solid phase-bound goat IgG anti-C1q to trap C1q and the
same biotin-labeled Ab to reveal bound C1q followed by alkaline phos-
phatase-conjugated streptavidin (C). Data from five independent experi-
ments are shown and represent the mean 6 SD.
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Because gC1qR was found to be associated with b1 integrin on
the surface of ECs upon binding to C1q (46), we considered the
possibility that this may also happen in our model system. To
address this issue, CTBs were incubated with solid phase-bound
C1q or FN, lysed, and sequentially immunoprecipitated on protein
G-Sepharose beads coupled with mAbs to gC1qR and anti-b1
integrin. As shown in Fig. 5A, immunoblot analysis revealed the
presence of a band comigrating with b1 integrin on gC1qR immu-
noprecipitates (IPs). Moreover, by using confocal analysis, we found
that gC1qR colocalizes with b1 integrin at points of contact between
CTBs and C1q (Fig. 5B). Together, these results suggest that CTB
binding to C1q results in the association of gC1qR with b1 integrins.
Binding of trophoblast cells to C1q enhances ERK1/2 MAPK
phosphorylation
Based on the ability of C1q to support trophoblast adhesion and
migration, we decided to investigate if binding of C1q to tropho-
blast cells could also result in the activation of signaling molecules
involved in the regulation of cellular processes associated with ad-
hesive and migratory functions. For this purpose, freshly isolated
CTBs were allowed to adhere to wells coated with C1q, FN, or BSA
for different lengths of time at 37˚C, and the phosphorylation status
of ERK1/2 MAPKs on total cell lysates was evaluated by immu-
noblotting. As shown in Fig. 6, binding of CTBs to C1q resulted in the
activation of ERK1/2 MAPKs that was already evident at 5 min and
still persisted 20 min poststimulation. Interestingly, the levels of
ERK1/2 MAPK phosphorylation evaluated by densitometric analysis
in CTBs bound to C1q were comparable to those observed in cells
adherent to FN and were ∼5-fold higher than the levels observed in
BSA-stimulated CTBs (Fig. 6). The involvement of ERK1/2 MAPK
in the process of trophoblast motility was further supported by the
finding that the synthetic inhibitor PD 098059 (25 mM; Calbiochem-
Novabiochem), which specifically prevents activation of the ERK-
activating kinase MAPK/ERK-1 (47, 48), completely inhibited CTB
migration through C1q (data not shown).
Defective invasion of CTBs in C1q2/2 mice associated with
embryo growth restriction
To examine the actual contribution of C1q to pregnancy outcomes,
we performed a gross and microscopic time-course analysis of im-
plantation sites from C1q2/2 mice and wild-type (WT) controls.
Increased fetal resorption frequency (Fig. 7A) and diminished
fetal weight (Fig. 7B) were observed in C1q-deficient mice at day
15 of pregnancy compared with WT mice. In accordance with the
increased fetal death observed at day 15 of pregnancy, C1q-
deficient mice showed smaller litter sizes at birth when com-
pared with WT mice (Fig. 7C).
Histopathologic analysis of implantation sites from C1q2/2mice
at different time points of gestation from 7.5–14.5 d revealed signs
of impaired development as compared with WT controls matched
for gestational age. Changes were mostly noticed starting from day
9.5 and were characterized by impaired labyrinth development (Fig.
8, upper panels), lower degree of vascular remodeling (Fig. 8, lower
panels), and marked edema in the interstitium of decidual stroma.
In addition, staining of decidua from C1q2/2 mice for cytokeratin
revealed marked reduction in trophoblast invasion and nearly com-
plete absence of periarteriolar clusters of trophoblasts compared
with the decidua obtained from gestational age-matched WT mice.
Discussion
Trophoblast invasion of decidua is a critical process for placentation
and embryo implantation and is regulated by a series of integrated
adhesion and signaling events that include the cross talk between
trophoblast and decidual cells requiring interaction between cell-
surface adhesion molecules and ECM proteins. The data presented
in this study suggest that C1q synthesized and secreted by EVTs is
part of this complex network and is used by EVTs to migrate inside
the decidua.
While searching for complement involvement in tissue remod-
eling that occurs in maternal deciduas following embryo implanta-
tion, we observed deposits of C1q on decidual stroma in the absence
of C4 and C3. This finding was unexpected because C1q is usually
detected on cells and tissues in pathological conditions associated
with complement activation through the classical pathway. As a re-
sult, biologically active products that are primarily involved in the
removal of immune complexes, apoptotic cells, and infectious and
other harmful agents are released. Even more surprising was the
observation that the deposits of C1q inmaternal deciduaweremainly
seen in areas of trophoblast invasion, suggesting that C1q may have
been synthesized locally and used for some special functions unre-
lated to complement activation. Staining for C1q was also observed
in the villi, particularly in the Hofbauer cells that displayed a strong
signal. This is not surprising because they belong to the monocyte/
macrophage lineage known to be a major source of C1q (49–51).
A low level of staining was also apparent in villous trophoblast
cells, most likely due to C1q deposits from maternal blood, as these
cells were found to lack the C1qC message required for the assem-
bly of C1q.
FIGURE 4. Involvement of gC1q R and b1 integrin in trophoblast–C1q
interaction. A, FAST Dil-labeled (Molecular Probes, Invitrogen) CTBs
were allowed to adhere to C1q in the presence of mAbs anti-gC1qR 60.11
and 74.5.2, rabbit IgG anti-cC1qR, mAb P5D2 directed to b1 integrin,
mAb P5H4 to a4 integrin, mouse IgG1 isotype control, or medium alone.
The results are given as percent of cell adhesion. B, Migration of CTBs
through inserts of transwells coated with C1q was evaluated using DCCMs
as a chemotactic stimulus in the presence of mAb 60.11, mAb P5D2, mAb
P5H4, or mouse IgG1 isotype control. The results are given as percent of
cell migration. Data from five independent experiments are shown and
represent the mean 6 SD. pp , 0.05; ppp , 0.01; pppp , 5 3 1025.
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The extracellular deposition of C1q in close proximity to the
surface of trophoblasts invading the decidua and, more importantly,
the cytoplasmic staining of EVTs for this complement component,
suggest that EVT may be a good candidate for the local production
of C1q. Evidence supporting this conclusion was obtained by the
finding that EVTs expressed the messages for the three chains of
C1q and secreted a detectable amount of the molecule in the culture
supernatant. C1q is one of the few complement components syn-
thesized at the extrahepatic sites, as suggested by the observation
that bone marrow transplants from complement-sufficient mice
restore C1q levels in C1q-deficient animals (52). Besides cells of
the monocyte/macrophage lineage, other cell types contribute to
the production of C1q, including follicular dendritic cells and in-
terdigitating cells (53), fibroblasts (54), and epithelial cells of the
intestinal and urogenital tracts (55). Our data suggest that decidual
tissue is an important source of C1q in pregnancy and contributes to
its local synthesis both with EVTs and, as recently reported, with
the ECs of spiral arteries (29). C1q secreted by DECs binds avidly
to the cell surface and acts as a physical link between endovascular
trophoblasts and DECs (29).
The strong staining of EVTs for C1q explains the preferential
localization of this complement component at sites of trophoblast
invasion. The association of C1q with the invasive phenotype of tro-
phoblast cells is further supported by the finding that this protein is
synthesized exclusively by trophoblasts expressing HLA-G, a well-
FIGURE 5. Colocalization gC1qR/b1 integrin. A, Western blot analysis of cell lysates from CTBs left to adhere to C1q (20 mg/ml) or FN (20 mg/ml) for 30
min at 37˚C and immunoprecipitated first with normal mouse IgG and then either with mAb 60.11 anti-gC1qR or mAb 4B4 anti-b1 integrin subunit. The
presence of b1 integrin subunit (130 kDa) and gC1qR (33 kDa) was revealed using rabbit polyclonal Abs. These results are representative of one out of three
independent experiments. B, Surface distribution of gC1qR and b1 integrin molecules on CTB cells allowed to adhere to C1q for 1 h at 37˚C. Postfixation, the
cells were immunostained for gC1qR (green) and for b1 integrin (red), as detailed inMaterials and Methods and then examined by confocal microscopy. Ba,
A representative field of a z-step (xy) analysis and the corresponding z projections (yz and xz). A representative colocalization analysis of gC1qR (Bb) and b1
integrin (Bc). Bd, Merged image for gC1qR and b1 integrin showing several spots (pseudocolored in gray by the software) of evidence of the presence of both
signals in the plasma membrane of several cells. Be, The relative colocalization graph indicating the pixels of the colocalized signals (yellow ellipse, ROI)
calculated by colocalization function of Leica Confocal Software (Leica Microsystems). Original magnification 3200. ROI, region of interest.
FIGURE 6. Binding of trophoblast cells to C1q enhances ERK1/2 MAPK
phosphorylation. CTBs were allowed to adhere to C1q-, FN-, or BSA-coated
wells for different lengths of time, and the phosphorylation status of ERK1/2
MAPKs (42 and 44 kDa) was evaluated on total cell lysates by immuno-
blotting. The amount of ERK and p-ERK1/2 MAPK was quantified by den-
sitometric analysis using the ImageJ 1.37v program (National Institutes of
Health) and expressed as absolute value as well as percentage of p-ERK.
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known marker of EVT. Thus, C1q can be considered as an addi-
tional marker of EVT, and its synthesis can be added to the list of
phenotypic changes of decidual trophoblasts, including the ex-
pression pattern of adhesion molecules (56) and the secretion of
hyperglycosylate human chorionic gonadotropin (57).
The recognition that C1q secreted by EVT as a soluble molecule
is deposited on decidual stroma in the absence of C4 and C3 led us
to hypothesize that trophoblast cells may use C1q to invade the
decidua. This process requires interaction of C1q with proteins of
the ECM present in the decidua with a characteristic distribution in
areas of trophoblast invasion and around the spiral arteries. Binding
of C1q to several of these proteins was documented by the results of
the immunoenzymatic assay and is in line with previous reports
showing interaction of C1q with FN (58), laminin (59), small
leucine-rich repeat proteins, and mucopolysaccharides including
heparin sulfate and dermatan sulfate (60).
Several pieces of evidence argue for gC1q as the portion of C1q
molecule involved in the promotion of trophoblast adhesion and
migration, and the most compelling one is that the effect of C1q
was reproduced with purified gC1q. Strictly related to this point is
the finding that EMILIN1, an important component of decidual
stroma and a member of C1q and TNF superfamily characterized by
a common gC1q signature domain (45), is also implicated in tro-
phoblast invasion of decidua (19). Equally important in this context
is our previous observation that CTBs only express gC1qR, which
selectively recognizes gC1q while failing to express the receptor for
the collagen portion of C1q (29). The role played by gC1qR–gC1q
interaction in trophoblast adhesion and migration is further sup-
ported by the inhibition obtained with mAb 60.11 to gC1qR, which
recognizes a C1q binding site on this receptor, whereas mAb 74.5.2,
which reacts with an epitope of gC1qR involved in the reaction with
the high m.w. kininogen (61), was ineffective.
Interaction of C1q with CTBs results in cell activation, as
suggested by the enhanced phosphorylation of ERK1/2 MAPK to
a level essentially similar to that observed in CTBs bound to FN.
This finding extends previous observation by Liu et al. (62), who
showed that activation of PI3K/AKT, ERK, and JNK pathways is
required for the chemotaxis of immature dendritic cells to C1q,
whereas activation of AKT and p38 pathways is needed for C1q-
mediated enhancement of mature dendritic cell chemotaxis to
CCL19. However, because gC1qR lacks direct access to the in-
tracellular compartment, the sole engagement of this receptor by
bound C1q is unlikely to deliver the activation signal to CTBs for
which the contribution of b1 integrin is required. The involvement
of a4b1 integrin expressed on the surface of invasive trophoblasts
(19, 20, 63) in C1q-mediated cell adhesion and migration is sug-
gested by the inhibition obtained with mAbs to a4 and b1 integ-
rins, the colocalization of this integrin with gC1qR on CTBs ad-
hering to bound C1q, and coprecipitation with the same receptor
in extract of these cells. Similar results were obtained by Feng and
colleagues (46), who showed that EC adhesion and spreading on
C1q-coated microtiter wells was prevented both by mAb 60.11 to
gC1qR and mAb to b1 integrins and that gC1qR and b1 integrin
cocaptured on C1q-bound ECs. Involvement of integrins in cell
activation by C1q has also been established on murine mast cells
that have been shown to express a2b1 integrin as a novel receptor
for the collagen-like sequence of C1q (64–66).
The best way to prove the in vivo relevance of our observations is
to evaluate pregnancy outcome in C1q-deficient patients. Un-
fortunately, this is difficult to ascertain because C1q deficiency is
a rare genetic defect and is often associated with a severe form of
systemic lupus erythematosus. However, judging from the reduced
litter size, the decreased fetal weight, and, more importantly, the
increased number of fetal losses observed in C1q knockout mice,
one can confidently conclude that the absence of C1q may impair
pregnancy outcome. This is in line with the deficient trophoblast
invasion and reduced labyrinth development and remodeling of
spiral arteries observed in pregnant C1q2/2 mice compared with
WT animals of the same gestational age.
In summary, we have shown that C1q secreted by migrating
CTB cells acts on the same cells through an autocrine mechanism to
promote decidual invasion and more generally regular pregnancy
outcome.
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